“…The heptapeptide was further identified in screenings with a teratogenic serotonin receptor inverse agonist (SB-236057) [ 108 ], different rRNA targets [ 109 ] and the following protein targets: monoclonal anti-angiogenic antibody [ 110 ], melanoma inhibitory activity (MIA) protein [ 111 ], prion protein [ 112 ], chromatin high mobility group protein 1 [ 23 ] and an epitope on kidney-specific H-ATPase subunit G3 [ 113 ]. Although the binding of the LPLTPLP peptide to SB-236057, monoclonal anti-angiogenic antibody and MIA was not or could not be demonstrated [ 108 , 110 , 111 ], its affinity towards rRNA, prion protein and HMGB1 was confirmed by on-bead fluorescence assay, ELISA and Far-Western blotting, respectively [ 23 , 109 , 112 ]. Various authors have identified different proteins that contain regions with a high degree of homology to the selected LPLTPLP [ 108 , 112 , 113 ].…”